The viral paradigm in type 1 diabetes: Who are the main suspects?

Autoimmunity Reviews

Volumn 15, Issue 10, 2016, Pages 964-969

  Rodriguez Calvo, Teresa ^a   Sabouri, Somayeh ^a   Anquetil, Florence ^a   von Herrath, Matthias G ^a,b  

^a LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

^b NOVO NORDISK INC   (United States)

Author keywords

Autoimmunity; Environmental factors; Type 1 diabetes; Viruses

Indexed keywords

AUTOIMMUNITY; ENTEROVIRUS; ENTEROVIRUS INFECTION; HERPES VIRUS INFECTION; HERPESVIRIDAE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; REVIEW; ANIMAL; COMPLICATION; IMMUNOLOGY; PANCREAS ISLET; VIROLOGY; VIRUS INFECTION;

ANIMALS; AUTOIMMUNITY; DIABETES MELLITUS, TYPE 1; HUMANS; ISLETS OF LANGERHANS; VIRUS DISEASES;

EID: 84990247532     PISSN: 15689972     EISSN: 18730183     Source Type: Journal    
DOI: 10.1016/j.autrev.2016.07.019     Document Type: Review

References (79)

1. [1] Oxforddictionaries.com.
2. [2] Van Blerkom, L.M., Role of viruses in human evolution. Am J Phys Anthropol(Suppl. 37), 2003, 14–46.
3. [3] Villarreal, L., The widespread evolutionary significance of viruses. Domingo, E., Colin, P., Holland, J., (eds.) Origin and evolution of viruses, 2nd ed., 2008, Elsevier, 477–516.
4. [4] Comparative studies of RNA virus evolution. Holmes, E., Domingo, E., Colin, P., Holland, J., (eds.) Origin and evolution of viruses, 2nd ed., 2008, Elsevier, 119–134.
5. [5] Zinkernagel, R.M., Hengartner, H., Stitz, L., On the role of viruses in the evolution of immune responses. Br Med Bull 41:1 (1985), 92–97.
6. [6] Pallansch, M., Oberste, M., Whitton, J., Knipe, D., Howley, P., (eds.) Enteroviruses: polioviruses, coxsackieviruses, echoviruses, and newer enteroviruses Fields Virology, vol. 2013, 2013, Lippincott Williams and Wilkins, Philadelphia, PA, 490–530.
7. [7] Yoon, J.W., Austin, M., Onodera, T., Notkins, A.L., Isolation of a virus from the pancreas of a child with diabetic ketoacidosis. N Engl J Med 300:21 (1979), 1173–1179.
8. [8] Ronningen, K.S., Norris, J.M., Knip, M., Environmental trigger(s) of type 1 diabetes: why is it so difficult to identify?. BioMed Res Int, 2015, 2015, 847906.
9. [9] Tapia, G., Cinek, O., Rasmussen, T., Witso, E., Grinde, B., Stene, L.C., et al. Human enterovirus RNA in monthly fecal samples and islet autoimmunity in Norwegian children with high genetic risk for type 1 diabetes: the MIDIA study. Diabetes Care 34:1 (2011), 151–155.
10. [10] Cinek, O., Stene, L.C., Kramna, L., Tapia, G., Oikarinen, S., Witso, E., et al. Enterovirus RNA in longitudinal blood samples and risk of islet autoimmunity in children with a high genetic risk of type 1 diabetes: the MIDIA study. Diabetologia 57:10 (2014), 2193–2200.
11. [11] Stene, L.C., Oikarinen, S., Hyoty, H., Barriga, K.J., Norris, J.M., Klingensmith, G., et al. Enterovirus infection and progression from islet autoimmunity to type 1 diabetes: the Diabetes and Autoimmunity Study in the Young (DAISY). Diabetes 59:12 (2010), 3174–3180.
12. [12] Laitinen, O.H., Honkanen, H., Pakkanen, O., Oikarinen, S., Hankaniemi, M.M., Huhtala, H., et al. Coxsackievirus B1 is associated with induction of beta-cell autoimmunity that portends type 1 diabetes. Diabetes 63:2 (2014), 446–455.
13. [13] Lee, H.S., Briese, T., Winkler, C., Rewers, M., Bonifacio, E., Hyoty, H., et al. group, T. s., Next-generation sequencing for viruses in children with rapid-onset type 1 diabetes. Diabetologia 56:8 (2013), 1705–1711.
14. [14] Krogvold, L., Edwin, B., Buanes, T., Frisk, G., Skog, O., Anagandula, M., et al. Detection of a low-grade enteroviral infection in the islets of Langerhans of living patients newly diagnosed with type 1 diabetes. Diabetes 64:5 (2015), 1682–1687.
15. [15] Richardson, S.J., Willcox, A., Bone, A.J., Foulis, A.K., Morgan, N.G., The prevalence of enteroviral capsid protein vp1 immunostaining in pancreatic islets in human type 1 diabetes. Diabetologia 52:6 (2009), 1143–1151.
16. [16] Ylipaasto, P., Klingel, K., Lindberg, A.M., Otonkoski, T., Kandolf, R., Hovi, T., et al. Enterovirus infection in human pancreatic islet cells, islet tropism in vivo and receptor involvement in cultured islet beta cells. Diabetologia 47:2 (2004), 225–239.
17. [17] Marroqui, L., Lopes, M., dos Santos, R.S., Grieco, F.A., Roivainen, M., Richardson, S.J., et al. Differential cell autonomous responses determine the outcome of coxsackievirus infections in murine pancreatic alpha and beta cells. eLife, 4, 2015, e06990.
18. [18] Gallagher, G.R., Brehm, M.A., Finberg, R.W., Barton, B.A., Shultz, L.D., Greiner, D.L., et al. Viral infection of engrafted human islets leads to diabetes. Diabetes 64:4 (2015), 1358–1369.
19. [19] Chen, T., Hudnall, S.D., Anatomical mapping of human herpesvirus reservoirs of infection. Mod Pathol 19:5 (2006), 726–737.
20. [20] Sun, Y., Pei, W., Wu, Y., Yang, Y., An association of herpes simplex virus type 1 infection with type 2 diabetes. Diabetes Care 28:2 (2005), 435–436.
21. [21] Abendroth, A., Kinchington, P.R., Slobedman, B., Varicella zoster virus immune evasion strategies. Curr Top Microbiol Immunol 342 (2010), 155–171.
22. [22] Lungu, O., Annunziato, P.W., Gershon, A., Staugaitis, S.M., Josefson, D., LaRussa, P., et al. Reactivated and latent varicella–zoster virus in human dorsal root ganglia. Proc Natl Acad Sci U S A 92:24 (1995), 10980–10984.
23. [23] Okamoto, S., Hata, A., Sadaoka, K., Yamanishi, K., Mori, Y., Comparison of varicella–zoster virus-specific immunity of patients with diabetes mellitus and healthy individuals. J Infect Dis 200:10 (2009), 1606–1610.
24. [24] Parkkonen, P., Hyoty, H., Ilonen, J., Reijonen, H., Yla-Herttuala, S., Leinikki, P., Antibody reactivity to an Epstein–Barr virus BERF4-encoded epitope occurring also in Asp-57 region of HLA-DQ8 beta chain. Childhood Diabetes in Finland Study Group. Clin Exp Immunol 95:2 (1994), 287–293.
25. [25] Hyoty, H., Taylor, K.W., The role of viruses in human diabetes. Diabetologia 45:10 (2002), 1353–1361.
26. [26] Hyoty, H., Rasanen, L., Hiltunen, M., Lehtinen, M., Huupponen, T., Leinikki, P., Decreased antibody reactivity to Epstein–Barr virus capsid antigen in type 1 (insulin-dependent) diabetes mellitus. APMIS Acta Pathol Microbiol Immunol Scand 99:4 (1991), 359–363.
27. [27] Bian, X., Wallstrom, G., Davis, A., Wang, J., Park, J., Throop, A., et al. Immunoproteomic profiling of antiviral antibodies in new-onset type 1 diabetes using protein arrays. Diabetes 65:1 (2016), 285–296.
28. [28] Fujiya, A., Ochiai, H., Mizukoshi, T., Kiyota, A., Shibata, T., Suzuki, A., et al. Fulminant type 1 diabetes mellitus associated with a reactivation of Epstein–Barr virus that developed in the course of chemotherapy of multiple myeloma. J Diabetes Invest 1:6 (2010), 286–289.
29. [29] Hiemstra, H.S., Schloot, N.C., van Veelen, P.A., Willemen, S.J., Franken, K.L., van Rood, J.J., et al. Cytomegalovirus in autoimmunity: T cell crossreactivity to viral antigen and autoantigen glutamic acid decarboxylase. Proc Natl Acad Sci U S A 98:7 (2001), 3988–3991.
30. [30] Jenson, A.B., Rosenberg, H.S., Notkins, A.L., Pancreatic islet-cell damage in children with fatal viral infections. Lancet 2:8190 (1980), 354–358.
31. [32] Aarnisalo, J., Veijola, R., Vainionpaa, R., Simell, O., Knip, M., Ilonen, J., Cytomegalovirus infection in early infancy: risk of induction and progression of autoimmunity associated with type 1 diabetes. Diabetologia 51:5 (2008), 769–772.
32. [33] Hiltunen, M., Hyoty, H., Karjalainen, J., Leinikki, P., Knip, M., Lounamaa, R., et al. Serological evaluation of the role of cytomegalovirus in the pathogenesis of IDDM: a prospective study. The Childhood Diabetes in Finland Study Group. Diabetologia 38:6 (1995), 705–710.
33. [34] Ivarsson, S.A., Lindberg, B., Nilsson, K.O., Ahlfors, K., Svanberg, L., The prevalence of type 1 diabetes mellitus at follow-up of Swedish infants congenitally infected with cytomegalovirus. Diabet Med 10:6 (1993), 521–523.
34. [35] Pak, C.Y., Eun, H.M., McArthur, R.G., Yoon, J.W., Association of cytomegalovirus infection with autoimmune type 1 diabetes. Lancet 2:8601 (1988), 1–4.
35. [36] Donati, D., Akhyani, N., Fogdell-Hahn, A., Cermelli, C., Cassiani-Ingoni, R., Vortmeyer, A., et al. Detection of human herpesvirus-6 in mesial temporal lobe epilepsy surgical brain resections. Neurology 61:10 (2003), 1405–1411.
36. [37] Fox, J.D., Briggs, M., Ward, P.A., Tedder, R.S., Human herpesvirus 6 in salivary glands. Lancet 336:8715 (1990), 590–593.
37. [38] Roush, K.S., Domiati-Saad, R.K., Margraf, L.R., Krisher, K., Scheuermann, R.H., Rogers, B.B., et al. Prevalence and cellular reservoir of latent human herpesvirus 6 in tonsillar lymphoid tissue. Am J Clin Pathol 116:5 (2001), 648–654.
38. [39] Harma, M., Hockerstedt, K., Lautenschlager, I., Human herpesvirus-6 and acute liver failure. Transplantation 76:3 (2003), 536–539.
39. [40] Kondo, K., Kondo, T., Okuno, T., Takahashi, M., Yamanishi, K., Latent human herpesvirus 6 infection of human monocytes/macrophages. J Gen Virol 72:Pt 6 (1991), 1401–1408.
40. [41] Bach, J.M., Otto, H., Jung, G., Cohen, H., Boitard, C., Bach, J.F., et al. Identification of mimicry peptides based on sequential motifs of epitopes derived from 65-kDa glutamic acid decarboxylase. Eur J Immunol 28:6 (1998), 1902–1910.
41. [42] Imagawa, A., Hanafusa, T., Fulminant type 1 diabetes—an important subtype in East Asia. Diabetes Metab Res Rev 27:8 (2011), 959–964.
42. [43] Di Luca, D., Mirandola, P., Ravaioli, T., Dolcetti, R., Frigatti, A., Bovenzi, P., et al. Human herpesviruses 6 and 7 in salivary glands and shedding in saliva of healthy and human immunodeficiency virus positive individuals. J Med Virol 45:4 (1995), 462–468.
43. [44] Kolehmainen, P., Koskiniemi, M., Oikarinen, S., Veijola, R., Simell, O., Ilonen, J., et al. Human parechovirus and the risk of type 1 diabetes. J Med Virol 85:9 (2013), 1619–1623.
44. [45] Nilsson, A.L., Vaziri-Sani, F., Broberg, P., Elfaitouri, A., Pipkorn, R., Blomberg, J., et al. Serological evaluation of possible exposure to Ljungan virus and related parechovirus in autoimmune (type 1) diabetes in children. J Med Virol 87:7 (2015), 1130–1140.
45. [46] Nilsson, A.L., Vaziri-Sani, F., Andersson, C., Larsson, K., Carlsson, A., Cedervall, E., et al. Relationship between Ljungan virus antibodies, HLA-DQ8, and insulin autoantibodies in newly diagnosed type 1 diabetes children. Viral Immunol 26:3 (2013), 207–215.
46. [47] Tapia, G., Cinek, O., Rasmussen, T., Grinde, B., Stene, L.C., Ronningen, K.S., Longitudinal study of parechovirus infection in infancy and risk of repeated positivity for multiple islet autoantibodies: the MIDIA study. Pediatr Diabetes 12:1 (2011), 58–62.
47. [48] Honeyman, M.C., Coulson, B.S., Stone, N.L., Gellert, S.A., Goldwater, P.N., Steele, C.E., et al. Association between rotavirus infection and pancreatic islet autoimmunity in children at risk of developing type 1 diabetes. Diabetes 49:8 (2000), 1319–1324.
48. [49] Lempainen, J., Tauriainen, S., Vaarala, O., Makela, M., Honkanen, H., Marttila, J., et al. Interaction of enterovirus infection and cow's milk-based formula nutrition in type 1 diabetes-associated autoimmunity. Diabetes Metab Res Rev 28:2 (2012), 177–185.
49. [50] Graham, K.L., Sanders, N., Tan, Y., Allison, J., Kay, T.W., Coulson, B.S., Rotavirus infection accelerates type 1 diabetes in mice with established insulitis. J Virol 82:13 (2008), 6139–6149.
50. [51] Pane, J.A., Webster, N.L., Coulson, B.S., Rotavirus activates lymphocytes from non-obese diabetic mice by triggering toll-like receptor 7 signaling and interferon production in plasmacytoid dendritic cells. PLoS Pathog, 10(3), 2014, e1003998.
51. [52] Honeyman, M.C., Stone, N.L., Falk, B.A., Nepom, G., Harrison, L.C., Evidence for molecular mimicry between human T cell epitopes in rotavirus and pancreatic islet autoantigens. J Immunol 184:4 (2010), 2204–2210.
52. [53] Pane, J.A., Dang, V.T., Holloway, G., Webster, N.L., Coulson, B.S., VP7 of Rhesus monkey rotavirus RRV contributes to diabetes acceleration in association with an elevated anti-rotavirus antibody response. Virology 468-470 (2014), 504–509.
53. [54] Honeyman, M.C., Laine, D., Zhan, Y., Londrigan, S., Kirkwood, C., Harrison, L.C., Rotavirus infection induces transient pancreatic involution and hyperglycemia in weanling mice. PLoS One, 9(9), 2014, e106560.
54. [55] Xia, C.Q., Peng, R., Chernatynskaya, A.V., Yuan, L., Carter, C., Valentine, J., et al. Increased IFN-alpha-producing plasmacytoid dendritic cells (pDCs) in human Th1-mediated type 1 diabetes: pDCs augment Th1 responses through IFN-alpha production. J Immunol 193:3 (2014), 1024–1034.
55. [56] Nenna, R., Papoff, P., Moretti, C., Pierangeli, A., Sabatino, G., Costantino, F., et al. Detection of respiratory viruses in the 2009 winter season in Rome: 2009 influenza A (H1N1) complications in children and concomitant type 1 diabetes onset. Int J Immunopathol Pharmacol 24:3 (2011), 651–659.
56. [57] Valdes, C., Unanue, N., Hernandez, M., Garcia, R., Castro, M., Vasquez, L., et al. Is there a link between influenza and type I diabetes? Increased incidence of TID during the pandemic H1N1 influenza of 2009 in Chile. Pediatr Endocrinol Rev 11:2 (2013), 161–166.
57. [58] Kondrashova, A., Nurminen, N., Patrikainen, M., Huhtala, H., Lehtonen, J., Toppari, J., et al. Influenza A virus antibodies show no association with pancreatic islet autoantibodies in children genetically predisposed to type 1 diabetes. Diabetologia 58:11 (2015), 2592–2595.
58. [59] Gale, E.A., Congenital rubella: citation virus or viral cause of type 1 diabetes?. Diabetologia 51:9 (2008), 1559–1566.
59. [60] Honeyman, M.C., Harrison, L.C., Congenital rubella, diabetes and HLA. Diabetologia 52:2 (2009), 371–372 [author reply 373].
60. [61] Burgess, M.A., Forrest, J.M., Congenital rubella and diabetes mellitus. Diabetologia 52:2 (2009), 369–370 [author reply 373].
61. [62] Ou, D., Mitchell, L.A., Metzger, D.L., Gillam, S., Tingle, A.J., Cross-reactive rubella virus and glutamic acid decarboxylase (65 and 67) protein determinants recognised by T cells of patients with type I diabetes mellitus. Diabetologia 43:6 (2000), 750–762.
62. [63] Ramondetti, F., Sacco, S., Comelli, M., Bruno, G., Falorni, A., Iannilli, A., et al. Type 1 diabetes and measles, mumps and rubella childhood infections within the Italian Insulin-dependent Diabetes Registry. Diabet Med 29:6 (2012), 761–766.
63. [64] Johnson, W.E., Endogenous retroviruses in the genomics era. Annu Rev Virol 2:1 (2015), 135–159.
64. [65] Mack, M., Bender, K., Schneider, P.M., Detection of retroviral antisense transcripts and promoter activity of the HERV-K(C4) insertion in the MHC class III region. Immunogenetics 56:5 (2004), 321–332.
65. [66] Conrad, B., Weissmahr, R.N., Boni, J., Arcari, R., Schupbach, J., Mach, B., A human endogenous retroviral superantigen as candidate autoimmune gene in type I diabetes. Cell 90:2 (1997), 303–313.
66. [67] Stauffer, Y., Marguerat, S., Meylan, F., Ucla, C., Sutkowski, N., Huber, B., et al. Interferon-alpha-induced endogenous superantigen. a model linking environment and autoimmunity. Immunity 15:4 (2001), 591–601.
67. [68] Nexo, B.A., Villesen, P., Nissen, K.K., Lindegaard, H.M., Rossing, P., Petersen, T., et al. Are human endogenous retroviruses triggers of autoimmune diseases? Unveiling associations of three diseases and viral loci. Immunol Res 64:1 (2016), 55–63.
68. [69] Mason, M.J., Speake, C., Gersuk, V.H., Nguyen, Q.A., O'Brien, K.K., Odegard, J.M., et al. Low HERV-K(C4) copy number is associated with type 1 diabetes. Diabetes 63:5 (2014), 1789–1795.
69. [70] Boettler, T., von Herrath, M., Protection against or triggering of Type 1 diabetes? Different roles for viral infections. Expert Rev Clin Immunol 7:1 (2011), 45–53.
70. [71] Coppieters, K.T., Wiberg, A., Tracy, S.M., von Herrath, M.G., Immunology in the clinic review series: focus on type 1 diabetes and viruses: the role of viruses in type 1 diabetes: a difficult dilemma. Clin Exp Immunol 168:1 (2012), 5–11.
71. [72] Soltesz, G., Patterson, C.C., Dahlquist, G., Group, E.S., Worldwide childhood type 1 diabetes incidence—what can we learn from epidemiology?. Pediatr Diabetes 8:Suppl. 6 (2007), 6–14.
72. [73] Morgan, E., Halliday, S.R., Campbell, G.R., Cardwell, C.R., Patterson, C.C., Vaccinations and childhood type 1 diabetes mellitus: a meta-analysis of observational studies. Diabetologia 59:2 (2016), 237–243.
73. [74] Graves, P.M., Barriga, K.J., Norris, J.M., Hoffman, M.R., Yu, L., Eisenbarth, G.S., et al. Lack of association between early childhood immunizations and beta-cell autoimmunity. Diabetes Care 22:10 (1999), 1694–1697.
74. [75] Krogvold, L., Edwin, B., Buanes, T., Ludvigsson, J., Korsgren, O., Hyöty, H., Frisk, G., Hanssen, K.F., Dahl-Jørgensen, K., Pancreatic biopsy by minimal tail resection in live adult patients at the onset of type 1 diabetes: experiences from the DiViD study. Diabetologia. 57:4 (2014), 841–843.
75. [76] Laiho, J.E., Oikarinen, M., Richardson, S.J., Frisk, G., Nyalwidhe, J., Burch, T.C., Morris, M.A., Oikarinen, S., Pugliese, A., Dotta, F., Campbell-Thompson, M., Nadler, J., Morgan, N.G., Hyöty, H., JDRF nPOD-Virus Group. Relative sensitivity of immunohistochemistry, multiple reaction monitoring mass spectrometry, in situ hybridization and PCR to detect Coxsackievirus B1 in A549 cells. J Clin Virol. 77 (2016), 21–28.
76. [77] Tracy, S., Smithee, S., Alhazmi, A., Chapman, N., Coxsackievirus can persist in murine pancreas by deletion of 5' terminal genomic sequences. J Med Virol. 87:2 (2015), 240–247.
77. [78] Salahuddin, S.Z., Ablashi, D.V., Markham, P.D., Josephs, S.F., Sturzenegger, S., Kaplan, M., Halligan, G., Biberfeld, P., Wong-Staal, F., Kramarsky, B., Isolation of a new virus, HBLV, in patients with lymphoproliferative disorders. Science. 234:4776 (1986), 596–601.
78. [79] TEDDY Study Group, The Environmental Determinants of Diabetes in the Young (TEDDY) Study. Ann N Y Acad Sci. 1150 (2008), 1–13.
79. [80] Lönnrot, M., Lynch, K., Larsson, H.E., Lernmark, Å, Rewers, M., Hagopian, W., She, J.X., Simell, O., Ziegler, A.G., Akolkar, B., Krischer, J., Hyöty H. TEDDY Study Group. BMC Pediatr., 15, 2015, 24.